FOSTER CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: GERN), a hematology-focused biopharmaceutical company ...
Operator: Hello, and welcome to the Geron Corporation Second Quarter 2026 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn ...
Geron Corporation (ISIN US3741631036) traded at USD 1.30 on the Nasdaq on September 22, 2026, down 1.52 percent from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results